Literature DB >> 25273142

The human bitter taste receptor hTAS2R39 is the primary receptor for the bitterness of theaflavins.

Toyomi Yamazaki1, Miki Sagisaka, Riko Ikeda, Toshiyuki Nakamura, Noriko Matsuda, Takeshi Ishii, Tsutomu Nakayama, Tatsuo Watanabe.   

Abstract

We purified several hundred mgs of four major theaflavins (theaflavin, theaflavin-3-O-gallate, theaflavin-3'-O-gallate, and theaflavin-3,3'-O-digallate). Among the 25 hTAS2Rs expressed in HEK293T cells, hTAS2R39 and hTAS2R14 were activated by theaflavins. Both hTAS2R39 and hTAS2R14 responded to theaflavin-3'-O-gallate. In addition, hTAS2R39 was activated by theaflavin and theaflavin-3,3'-O-gallate, but not by theaflavin-3-O-gallate. In contrast, hTAS2R14 responded to theaflavin-3-O-gallate.

Entities:  

Keywords:  human bitter taste receptor; human bitter taste receptor 14 (hTAS2R14); human bitter taste receptor 39 (hTAS2R39); theaflavins

Mesh:

Substances:

Year:  2014        PMID: 25273142     DOI: 10.1080/09168451.2014.930326

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  3 in total

1.  Theaflavin-regulated Imd condensates control Drosophila intestinal homeostasis and aging.

Authors:  Qingshuang Cai; Shanming Ji; Mengwan Li; Sen Zheng; Xiuhong Zhou; Huimin Guo; Siyu Deng; Junyan Zhu; Daxiang Li; Zhongwen Xie
Journal:  iScience       Date:  2021-02-06

Review 2.  The Hidden One: What We Know About Bitter Taste Receptor 39.

Authors:  Florijan Jalševac; Ximena Terra; Esther Rodríguez-Gallego; Raúl Beltran-Debón; Maria Teresa Blay; Montserrat Pinent; Anna Ardévol
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-08       Impact factor: 5.555

3.  Important Sensory, Association, and Postprandial Perception Attributes Influencing Young Taiwanese Consumers' Acceptance for Taiwanese Specialty Teas.

Authors:  Bo-Kang Liou; Yih-Mon Jaw; George Chao-Chi Chuang; Newton N J Yau; Zhen-Yu Zhuang; Li-Fei Wang
Journal:  Foods       Date:  2020-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.